Anaphylactic Shock: Pathophysiology, Recognition, and Treatment

ABSTRACT

Anaphylaxis is a systemic, type I hypersensitivity reaction that often has fatal consequences. Anaphylaxis has a variety of causes including foods, latex, drugs, and hymenoptera venom. Epinephrine given early is the most important intervention. Adjunctive treatments include fluid therapy, H₁ and H₂ histamine receptor antagonists, corticosteroids, and bronchodilators; however these do not substitute for epinephrine. Patients with a history of anaphylaxis should be educated about their condition, especially with respect to trigger avoidance and in the correct use of epinephrine autoinjector kits. Such kits should be available to the sensitized patient at all times.

KEYWORDS

Anaphylaxis - epinephrine - shock - allergy

REFERENCES

• 1 Cohen S G, Zelaya-Quesada M. Portier, Richet, and the discovery of anaphylaxis: a centennial.  J Allergy Clin Immunol. 2002;  110 331-336
• 2 Neugut A I, Ghatak A T, Miller R L. Anaphylaxis in the United States: an investigation into its epidemiology.  Arch Intern Med. 2001;  161 15-21
• 3 Yocum M W, Butterfield J H, Klein J S et al.. Epidemiology an anaphylaxis in Olmsted County: a population-based study.  J Allergy Clin Immunol. 1999;  104 452-456
• 4 Kemp S F, Lockey R F. Anaphylaxis: a review of causes and mechanisms.  J Allergy Clin Immunol. 2002;  110 341-348
• 5 Joint Task Force on Practice Parameters . The diagnosis and management of anaphylaxis.  J Allergy Clin Immunol. 1998;  101 S465-S527
• 6 AAAAI Board of Directors . Anaphylaxis in schools and other child-care settings.  J Allergy Clin Immunol. 1998;  102 173-176
• 7 Long A. The nuts and bolts of peanut allergy.  N Engl J Med. 2002;  346 1320-1322
• 8 Dykewicz M S. Anaphylaxis and inflammation.  Clin Allergy Immunol. 2002;  16 401-409
• 9 Daffern P J, Schwartz L B. Allergic response. In Dale DC WebMD Scientific American Medicine. New York; WebMD Reference Group 2003
• 10 Kay A B. Allergy and allergic diseases: first of two parts.  N Engl J Med. 2001;  344 30-37
• 11 Sampson H A. Peanut allergy.  N Engl J Med. 2002;  346 1294-1299
• 12 Kemp S F. Current concepts in pathophysiology, diagnosis, and management of anaphylaxis.  Immunol Allergy Clin North Am. 2001;  21 611-634
• 13 Pumphrey R SH. Lessons for management of anaphylaxis from a study of fatal reactions.  Clin Exp Allergy. 2000;  30 1144-1150
• 14 Hogan A D, Schwartz L B. Markers of mast cell degranulation.  Methods. 1997;  13 43-52
• 15 Brockow K, Vieluf D, Püschel K et al.. Increased postmortem serum mast cell tryptase in a fatal anaphylactoid reaction to nonionic radiocontrast medium.  J Allergy Clin Immunol. 1999;  104 237-238
• 16 Leung D YM, Sampson H A, Yunginger J W et al.. Effect of anti-IgE therapy in patients with peanut allergy.  N Engl J Med. 2003;  348 986-993
• 17 Merz B. Studying peanut anaphylaxis.  N Engl J Med. 2003;  348 975-976
• 18 Berger W E. Monoclonal anti-IgE antibody: a novel therapy for allergic airways disease.  Ann Allergy Asthma Immunol. 2002;  88 152-161
• 19 Kelso J M, Jones R T, Yunginger J W. Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin.  J Allergy Clin Immunol. 1993;  91 867-872
• 20 Crockett R E, Lockey R F. Vaccine hypersensitivity.  Immunol Allergy Clin North Am. 2001;  21 707-743
• 21 Kelso J M. The gelatin story.  J Allergy Clin Immunol. 1999;  103 200-202
• 22 Sakaguchi M, Nakayama T, Inouye S. Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines.  J Allergy Clin Immunol. 1996;  98 1058-1061
• 23 Sakaguchi M, Kaneda H, Inouye S. A case of anaphylaxis to gelatin included in erythropoietin products.  J Allergy Clin Immunol. 1999;  103 349-350
• 24 James J M, Zeiger R S, Lester M R et al.. Safe administration of influenza vaccine to patients with egg allergy.  J Pediatr. 1998;  133 624-628
• 25 American Academy of Pediatrics .Summaries of infectious diseases. In Pickering LK 2000 Red Book: Report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village, IL; American Academy of Pediatrics 2000 175: 357-358
• 26 Ownby D R. A history of latex allergy.  J Allergy Clin Immunol. 2002;  110 S27-S32
• 27 Condemi J J. Allergic reactions to natural rubber latex at home, to rubber products, and to cross-reacting foods.  J Allergy Clin Immunol. 2002;  110 S107-S110
• 28 Turjanmaa K, Alenius H, Reunala T, Palosuo T. Recent developments in latex allergy.  Curr Opin Allergy Clin Immunol. 2002;  2 407-412
• 29 Garabrant D H, Schweitzer S. Epidemiology of latex sensitization and allergies in health care workers.  J Allergy Clin Immunol. 2002;  110 S82-S95
• 30 Bauer X. Epidemiology of latex sensitization.  J Allergy Clin Immunol. 2003;  111 652
• 31 Garabrant D H, Schweitzer S. Reply.  J Allergy Clin Immunol. 2003;  111 652
• 32 Nettis E, Colanardi M C, Ferrannini A, Tursi A. Latex hypersensitivity: personal data and review of the literature.  Immunopharmacol Immunotoxicol. 2002;  24 315-334
• 33 Bautista E, Simons F ER, Simons K J et al.. Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock.  Int Arch Allergy Immunol. 2002;  128 151-164
• 34 Johnston S L, Unsworth J, Gompels M M. Adrenaline given outside the context of life threatening allergic reactions.  BMJ. 2003;  326 589-590
• 35 Simons F ER, Roberts J R, Gu X, Simons K J. Epinephrine absorption in children with a history of anaphylaxis.  J Allergy Clin Immunol. 1998;  101 33-37
• 36 Simons F ER, Gu X, Simons K J. Epinephrine absorption in adults: intramuscular versus subcutaneous injection.  J Allergy Clin Immunol. 2001;  108 871-873
• 37 Yocum M W, Khan D A. Assessment of patients who have experienced anaphylaxis: a 3-year survey.  Mayo Clin Proc. 1994;  69 16-23
• 38 Huang S. A survey of Epi-PEN use in patients with a history of anaphylaxis.  J Allergy Clin Immunol. 1998;  102 525-526
• 39 Grouhi M, Alshehri M, Hummel D, Roifman C M. Anaphylaxis and epinephrine auto-injector training: who will teach the teachers?.  J Allergy Clin Immunol. 1999;  104 190-193
• 40 Simons F ER, Gu X, Simons K J. Outdated EpiPen and EpiPen Jr autoinjectors: past their prime?.  J Allergy Clin Immunol. 2000;  105 1025-1030
• 41 Rusznak C, Peebles R S. Anaphylaxis.  Postgrad Med. 2002;  111 101-114